Indications:
. Short –term treatment of active duodenal ulcer
. Short-term treatment of active benign gastric ulcer
. Treatment of gastroesophageal reflux disease
. Maintenance of healing of erosive esophagitis
. Reduction of risk upper GI bleeding in critically ill patients
Dose :
. Duodenal ulcer: 20 mg once daily for 4 weeks
. Gastric ulcer: 40 mg once daily for 4 to 8 weeks
. GERD: 20 mg once daily for 4 weeks
. Erosive esophagitis: 20 mg once daily for 4 to 8 weeks
. Maintain healing of erosive esophagitis: 20 mg once daily for 4 weeks
. Reduction of risk upper gastrointestinal bleeding: 40 mg oral suspension only initially followed by 40 mg 6-8 hrs later daily for 14 days